BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35135432)

  • 1. Acute myeloid leukemia in a child with familial platelet disorder and a cryptic
    Dodson LM; Kurtz KJ; Marcogliese AN; Friend BD; Stevens AM; Fisher KE
    Pediatr Hematol Oncol; 2022 Sep; 39(6):580-585. PubMed ID: 35135432
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.
    Jongmans MC; Kuiper RP; Carmichael CL; Wilkins EJ; Dors N; Carmagnac A; Schouten-van Meeteren AY; Li X; Stankovic M; Kamping E; Bengtsson H; Schoenmakers EF; van Kessel AG; Hoogerbrugge PM; Hahn CN; Brons PP; Scott HS; Hoogerbrugge N
    Leukemia; 2010 Jan; 24(1):242-6. PubMed ID: 19946261
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
    Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
    Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
    Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
    Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
    Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
    Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.
    Cliburn JA; Uy JC; Swift S; Liesveld JL; Iqbal MA; Jajosky AN; Becker MW
    Int J Lab Hematol; 2024 Feb; 46(1):203-206. PubMed ID: 37953439
    [No Abstract]   [Full Text] [Related]  

  • 7. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
    Schlegelberger B; Heller PG
    Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial platelet disorder due to germline exonic deletions in
    Engvall M; Karlsson Y; Kuchinskaya E; Jörnegren Å; Mathot L; Pandzic T; Palle J; Ljungström V; Cavelier L; Hellström Lindberg E; Cammenga J; Baliakas P
    Leuk Lymphoma; 2022 Oct; 63(10):2311-2320. PubMed ID: 35533071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).
    Shiba N; Hasegawa D; Park MJ; Murata C; Sato-Otsubo A; Ogawa C; Manabe A; Arakawa H; Ogawa S; Hayashi Y
    Blood; 2012 Mar; 119(11):2612-4. PubMed ID: 22138511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele.
    Sakurai M; Kasahara H; Yoshida K; Yoshimi A; Kunimoto H; Watanabe N; Shiraishi Y; Chiba K; Tanaka H; Harada Y; Harada H; Kawakita T; Kurokawa M; Miyano S; Takahashi S; Ogawa S; Okamoto S; Nakajima H
    Blood Cancer J; 2016 Feb; 6(2):e392. PubMed ID: 26849013
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone Marrow Morphology Associated With Germline
    Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
    Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene of the issue: RUNX1 mutations and inherited bleeding.
    Morgan NV; Daly ME
    Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
    [No Abstract]   [Full Text] [Related]  

  • 15. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
    Homan CC; King-Smith SL; Lawrence DM; Arts P; Feng J; Andrews J; Armstrong M; Ha T; Dobbins J; Drazer MW; Yu K; Bödör C; Cantor A; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Fitzgibbon J; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Liu P; Godley LA; Schreiber AW; Hahn CN; Scott HS; Brown AL
    Haematologica; 2021 Nov; 106(11):3004-3007. PubMed ID: 34233450
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
    Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
    Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid neoplasms with germ line RUNX1 mutation.
    Hayashi Y; Harada Y; Huang G; Harada H
    Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
    Churpek JE; Garcia JS; Madzo J; Jackson SA; Onel K; Godley LA
    Leuk Lymphoma; 2010 Oct; 51(10):1931-5. PubMed ID: 20846103
    [No Abstract]   [Full Text] [Related]  

  • 19. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
    Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
    Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
    Owen C
    Leuk Res; 2010 Feb; 34(2):141-2. PubMed ID: 19695705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.